Many cells store neutral lipids, as triacylglycerol and sterol esters, in droplets. PAT-domain proteins form a conserved family of proteins that are localized at the surface of neutral lipid droplets. Two mammalian members of this family, Perilipin and adipose differentiationrelated protein, are involved in lipid storage and regulate lipolysis. Here, we describe the Drosophila PAT-family member Lsd2. We showed that Lsd2 is predominantly expressed in tissues engaged in high levels of lipid metabolism, the fat body and the germ line of females. Ultrastructural analysis in the germ line showed that Lsd2 localizes to the surface of lipid droplets. We have generated an Lsd2 mutant and described its phenotype. Mutant adults have a reduced level of neutral lipid content compared to wild type, showing that Lsd2 is required for normal lipid storage. In addition, ovaries from Lsd2 mutant females exhibit an abnormal pattern of accumulation of neutral lipids from midoogenesis, which results in reduced deposition of lipids in the egg. Consistent with its expression in the female germ line, we showed that Lsd2 is a maternal effect gene that is required for normal embryogenesis. This work demonstrates that Lsd2 has an evolutionarily conserved function in lipid metabolism and establishes Drosophila melanogaster as a new in vivo model for studies on the PAT-family of proteins. q
Introduction
Lipids are a major form of energy storage in animals. They are stored in the intracellular neutral lipid droplets of specialized tissues such as adipose tissue in mammals and the fat body in insects. Although initially found in fatrelated tissues, lipid droplets are organelles present in many, if not all, cell types (reviewed in Murphy, 2001) . Hence understanding the role of lipid metabolism at the level of the cell and whole organisms requires identification of the molecular mechanisms governing the biogenesis, trafficking and turnover of lipid droplets.
Lipid droplets are formed by a unique monolayer of amphipatic phospholipids surrounding a central hydrophobic core of neutral lipids, mainly consisting of triacylglycerol (TAG) and sterol esters. Two mammalian proteins have been studied for their property to specifically localize at the surface of these organelles: Perilipin and ADRP (adipocyte differentiation-related protein also known as adipophilin) (Blanchette-Mackie et al., 1995; Brasaemle et al., 1997b; Greenberg et al., 1991) . Besides this particular property, ADRP and Perilipin also show sequence similarity, especially in their N-terminal region where they are , 40% identical (Lu et al., 2001) . This N-terminal region, also present in another mammalian protein-TIP47, has been termed PAT domain (Lu et al., 2001) . TIP47 was originally identified as a protein required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network (Diaz and Pfeffer, 1998) . Although initially controversial (Barbero et al., 2001; Wolins et al., 2001) , the association of TIP47 to lipid droplets was recently verified (Miura et al., 2002) . The presence of a PAT domain correlates with the ability of proteins to localize to lipid droplets, although it has been recently shown not to be absolutely required (Garcia et al., 2003; McManaman et al., 2003; Targett-Adams et al., 2003) . Proteins with a PAT domain have been found in a wide variety of species, including Drosophila, and together form the PAT family (Lu et al., 2001) .
Perilipin and ADRP were originally identified as genes highly expressed in adipose tissue (Greenberg et al., 1991; Jiang and Serrero, 1992) . Further studies showed that Perilipin expression is restricted to differentiated adipocytes and steroidogenic cells (Greenberg et al., 1993; Servetnick et al., 1995) , whereas ADRP is more ubiquitously expressed (Brasaemle et al., 1997b; Heid et al., 1998) . In cultured cells, it has been shown that the ectopic expression of Perilipin or ADRP increases the capacity of cells to take up long fatty acids from the medium and to accumulate neutral lipids (Brasaemle et al., 2000; Gao and Serrero, 1999; Imamura et al., 2002; Souza et al., 2002) . Reciprocally, the addition of fatty acids to the culture medium stimulates neutral lipid accumulation in cells and increases intracellular levels of Perilipin or ADRP (Brasaemle et al., 1997a; Gao et al., 2000; Souza et al., 2002) . The reciprocal regulation of Perilipin/ ADRP and neutral lipids suggests that these two proteins have a role in lipid metabolism regulation.
The function of Perilipin in vivo has been analyzed in Perilipin-deficient mice (Martinez-Botas et al., 2000; Tansey et al., 2001) . These mice are viable, fertile and have normal size and weight. However, they have a reduced adipose tissue mass and are more muscular than controls. They are resistant to induced obesity and have a higher metabolic rate. These phenotypes are explained by the observed increase in basal lipolysis activity. This analysis together with data from cell culture experiments (Brasaemle et al., 2000; Souza et al., 1998 Souza et al., , 2002 led to the proposal that Perilipin has a protective role against lipases. The viability of Perilipin mutant mice could be explained by a partial compensation by other mammalian PAT-members. The identification of the in vivo role of the other members of this family awaits the generation of mutants.
Two Drosophila melanogaster members of the PAT family, Lsd1 and Lsd2, have been identified by BLAST search (Lu et al., 2001) . Both are equally related to any of the three mammalian members of the PAT family (Miura et al., 2002) . Ectopically expressed GFP-tagged Lsd1 or Lsd2 localize to lipid droplets, both in mammalian cell culture and in the fat body of Drosophila (Miura et al., 2002) . This shows that the targeting to lipid droplets is a feature conserved between Drosophila and mammalian PAT-family members.
We have analyzed the pattern of expression of Lsd2 and described an Lsd2 mutant. We showed that Lsd2 is enriched in the fat body of embryos and larvae and in the female germ line. We described mutant phenotypes related to defects in lipid metabolism in these tissues. Our results show that Lsd2 has a conserved function in lipid metabolism and establish Drosophila as a new in vivo model for the study of the PATfamily proteins.
Results

Isolation of a Drosophila Lsd2 mutant
To generate Lsd2 mutants, we carried out imprecise P element excisions on the EP(X)1614 line (obtained from the Berkeley Drosophila Genome Project (BDGP) (Rørth et al., 1998) ), in which an EP element is inserted approximately 600 bp upstream of the Lsd2 gene (Fig.  1A) . Northern blot analysis of poly(A þ )RNA isolated from homozygous flies from this line revealed that the EP insertion does not prevent Lsd2 expression (data not shown). We isolated an imprecise excision causing a small directional deletion of , 500 bp removing the genomic region located downstream of the original EP insertion site and extending towards, but not into, the 5 0 end of the longest expressed sequence tag (EST) available for Lsd2 from the BDGP (GH06230). The homozygous stock carrying this deletion is viable and fertile, as is the original EP(X)1614 line. Nevertheless, because of its position in the putative regulatory region of Lsd2, we suspected that this deletion might affect Lsd2 expression. To determine if that was the case, we performed Western blot analysis of adult protein extracts using a polyclonal antiserum raised against the longest open reading frame of 352 amino acids predicted for the Lsd2 protein. We detected a major band at , 50 kDa in crude extracts from wild type and EP(X)1614 flies (Fig. 1B) . This size is slightly greater than the predicted molecular weight of 38 kDa for the Lsd2 longest EST GH06230. Nevertheless, expression of this open reading frame in Escherichia coli generated a peptide with an apparent molecular mass of , 50 kDa in SDS-PAGE (data not shown). This band was absent in extract of the homozygous stock bearing the , 500 bp deletion upstream of Lsd2, even after maximal exposure of the blot. This demonstrates that the , 50 kDa form is encoded by Lsd2. A slightly fastermigrating band at , 45 kDa was also detected in wild type and EP(X)1614 adult extracts and could possibly correspond to a variant of Lsd2, as it was also absent in extract of Lsd2 1 homozygotes, although we cannot exclude that it results from proteolytic degradation of the major , 50 kDa form. We called the allele generated by the deletion Lsd2 1 : Based on the lack of protein reactivity of the Lsd2 1 extract with our anti-Lsd2 serum, we concluded that Lsd2 1 is a strong hypomorphic or null allele.
Drosophila Lsd2 is expressed in the fat body of embryos and larvae
As a first approach towards the investigation of Drosophila Lsd2, we examined its pattern of expression during embryo development by in situ hybridization (Fig. 2 , panels A -D). A high level of uniformly distributed Lsd2 transcript was found in the early stages of embryogenesis ( Fig. 2A) . The mRNA present at these stages is provided maternally (Edgar and Schubiger, 1986) . Upon cellularization of the embryo at stage 5, Lsd2 mRNA disappears except in the pole cells, the germ-line precursors at the posterior pole of the embryo (Fig. 2B) . Later, at stage 11, zygotic expression begins in the amnioserosa (data not shown). At stage 14, Lsd2 is relatively broadly expressed with an enrichment in the fat body and the midgut (Fig. 2C) .
At the end of embryogenesis, these tissues, together with the hindgut, are the main sites of Lsd2 expression (Fig. 2D) . The enrichment of Lsd2 in the fat body is particularly interesting because it is the main organ for lipid storage in insects (Canavoso et al., 2001) .
The enrichment of Lsd2 mRNA in the fat body at the end of embryogenesis prompted us to determine if Lsd2 is also expressed in larval fat body. The larval fat body is a site of active synthesis and storage of lipids while the larva rapidly grows and prepares for metamorphosis. We performed immunodetection of Lsd2 protein in wild type and Lsd2 1 homozygous third instar larvae, using our Lsd2 antiserum (Fig. 2 , panels E and F, respectively). At this stage, Lsd2 is mainly found in the fat body of wild-type larvae. Mutant larvae present no staining in this tissue, showing the specificity of the detection. The enrichment of Lsd2 protein in the larval fat body supports a role for this protein in lipid metabolism.
Drosophila Lsd2 is expressed in the germ line of females and localizes to the surface of lipid droplets
Because intense deposition of lipids is known to occur during oogenesis in the female germ line (Mahowald and Kambysellis, 1980) , we decided to investigate whether Lsd2 is expressed in this tissue. Whole-mount in situ hybridization on ovaries showed that Lsd2 mRNA is detected from mid-oogenesis (stages 7/8), where it accumulates in the oocyte (Fig. 3A) . From stage 10 on, Lsd2 mRNA expression was greatly increased throughout the germ line, as shown by the higher cytoplasmic staining in both the nurse cells and the oocyte. This accumulation is consistent with the previous detection of a high level of Lsd2 mRNA during the first stages of embryogenesis ( Fig. 2A) .
We also analyzed the expression of Lsd2 protein in the female germ line. Western blot analysis showed that the two previously described Lsd2 forms, at , 50 and , 45 kDa, are 1 ; is shown below and the 500 bp deletion is represented by a gap. (B) Western-blot analysis with the rat anti-Lsd2 serum. Crude protein extracts from whole flies (on the left) or from ovaries (on the right) were prepared from w118, EP(X)1614 and Lsd2 1 homozygotes. Asterisks indicate the ,50 kDa major band discussed in Section 2. Bottom panel shows the same blot stripped and probed with an anti-a-tubulin antibody as a loading control.
detected in extracts from wild type and EP(X)1614 ovaries, but are absent from Lsd2 1 ovaries (Fig. 1B) . The distribution of Lsd2 in ovaries was examined by immunofluorescence. A specific signal was first detected in the wild-type oocyte around mid-oogenesis (compare Fig. 3B and C) . Later, in stage 10 egg chambers, Lsd2 level increases in the cytoplasm of the nurse cells, reflecting the accumulation of Lsd2 mRNA observed at this stage (Fig. 3A) . However, Lsd2 was detected to a lower level in the oocyte despite the abundance of mRNA.
To investigate the subcellular distribution of Lsd2 in the germ line, we performed electron microscopy on ultrathin sections on stage 10 wild-type egg chambers ( Fig. 3D and E) . Both in nurse cells and in the oocyte, Lsd2 was mainly enriched at the surface of neutral lipid droplets. We also observed in the oocyte, but not in nurse cells, that lipid droplets are frequently connected to membrane-surrounded tubules (Fig. 3E) . The membrane of these tubules were labeled by the 1D3 monoclonal antibody recognizing last 12 amino acids of protein disulphide isomerase, an endoplasmic reticulum (ER) resident enzyme (Kondylis et al., 2001 ) (data not shown). The low electron-density content of these tubules together with their connection with lipid droplets suggests that they also contain lipids. However, Lsd2 was not detected on these tubules. 
Analysis of neutral lipid accumulation during oogenesis
The expression of Lsd2 in the female germ line and its localization to neutral lipid droplets prompted us to further examine the process of lipid accumulation in the germ line. To visualize neutral lipids we stained wild-type ovaries with Nile red, a fluorescent probe known to label neutral lipids (Brown et al., 1992) . Neutral lipids could be detected at a low level in both nurse cells and in the oocyte from stages 7/8 (Fig. 4A) . Whereas evenly dispersed in the oocyte, neutral lipids are enriched in a network surrounding the nuclei in the nurse cells. This pattern of accumulation in nurse cells is similar to the organization of the ER at these stages (Bobinnec et al., 2003) . Indeed, in a co-detection with a marker of the ER lumen, neutral lipids appear distributed similarly to the ER network (Fig. 4A ), although they do not perfectly co-localize.
At stage 10, a higher level of punctuate and evenly distributed lipid droplets was visible in the cytoplasm of nurse cells and, to a lower extent, in the oocyte (Fig. 4B) . At the onset of stage 11, the cytoplasmic content of the nurse cells is progressively delivered into the oocyte through a process called dumping, causing massive growth of the oocyte and resulting in higher fluorescent Nile red staining of the ooplasm compared to previous stages. At the end of stage 12, dumping is complete and nurse cells have transferred their cytoplasm into the oocyte. At this stage, traces of neutral lipid droplets were still visible, surrounding the nucleus, of the apoptotic nurse cells. At stage 14, the intense fluorescence visible throughout the oocyte cytoplasm revealed the high content of lipid droplets deposited at the end of oogenesis in the mature egg. Taken together, our results show that Lsd2 expression coincides with the accumulation of neutral lipid droplets during oogenesis.
Abnormal accumulation of neutral lipids in the germ line and eggs of Lsd2
1 females Lsd2 1 mutant nurse cells revealed a different pattern of neutral lipid accumulation beginning at stages 9/10 (Fig. 4C) . In contrast to the punctuated distribution in wild type, prominent patches of brightly stained neutral lipids were detected in the cytoplasm of mutant nurse cells. They often distribute in a radial pattern surrounding the nucleus of the nurse cells (see insets in Fig. 4C ). During stages 11/12, neutral lipids aggregate in enlarged lipid structures, sequestered in the apoptotic nurse cells. At the end of oogenesis, these structures persist, confined near the respiratory appendages at the antero-dorsal side of the oocyte. While we were generating the Lsd2 1 mutant, an independent P-insertion called P{SUPor-P}Lsd2 KG00149 was isolated in the Lsd2 5 0 UTR (generated by the Drosophila gene disruption Project, 2001) . Genetic complementation analysis between Lsd2 1 and P{SUPor-P}Lsd2 KG00149 revealed a defect in mutations are allelic and the phenotype is specific for the Lsd2 gene. This genetic analysis shows that Lsd2 is required for normal neutral lipid droplet accumulation in the nurse cells. Surprisingly, the aberrant pattern of neutral lipid accumulation observed in nurse cells was not seen in the oocyte. In addition, despite the obvious retention of neutral lipids in the nurse cells, the oocyte accumulates lipid droplets, as revealed by the increase of its fluorescence from stage 10 to 14. We concluded that Lsd2 is not strictly required for neutral lipid droplet accumulation in the oocyte. However, to test whether the aberrant accumulation of lipids in the mutant nurse cells could impair normal deposition into the oocyte, we quantified neutral lipids in early embryos (0 -1 h) (Fig. 5) . We detected 50% less TAG in embryos from mutant mothers compared to wild type, demonstrating that Lsd2 is required for normal deposition of neutral lipids in the oocyte. 
Embryos laid by Lsd2
1 females have a reduced hatching rate
We observed that embryos in the Lsd2 1 homozygous stock have a significantly lower hatching rate than those of a wild type control stock (Fig. 6 , compare nearly , 95% in control (a) and , 63% in mutant stocks (c)). This defect was also seen in the progeny of homozygous mutant females crossed with wild-type males (Fig. 6d) . This shows that the hatching defect was not suppressed by providing a wild type Lsd2 copy from males and indicated that it is dependent on the genotype of the mother, rather than of the zygote. Consistent with this, no defect was observed in the progeny of Lsd2 1 heterozygous females crossed with hemizygous mutant males in spite of the fact that half of the progeny was mutant (Fig. 6b) . This demonstrates that Lsd2 is a maternal effect gene. To further investigate the hatching defect, we collected embryos from wild type and Lsd2 1 homozygous mothers and examined their development at two time points. No significant difference was visible between the two populations after , 7 h of development, most embryos being at stage 11. However, after , 21 h, just before hatching, we observed clear differences between the wild type and the embryos of Lsd2 1 mothers. In the wild-type population, 99% of embryos presented an elongated larvalike morphology (late stage 17). In contrast, 78% of embryos from Lsd2 1 mothers ranged from a stage 17 embryo-shaped morphology to the wild type elongated larva-like morphology. Moreover, the remaining 22% of embryos from Lsd2 1 mothers appeared to have degenerated. Thus, the loss of viability of , 37% in the progeny of Lsd2 1 mothers results from developmental defects occurring after stage 11.
Lsd2
1 adults exhibit impaired lipid storage A further examination of the Lsd2 1 homozygous stock revealed that whereas larvae develop normally in a rich diet, they were less opaque than wild-type larvae (Fig. 7A) . This seemed to be due to the fact that the fat body of these larvae, easy to visualize because of the transparency of the body wall, is less developed than that of control larvae. To test whether the lipid storage function of the fat body is impaired in the mutant, we quantified the TAG content in adult flies (Fig. 7B ). We observed that the level of TAG was 27% lower in the mutant than in the wild type. This demonstrates that Lsd2, similarly to Perilipin in the mouse, is required for normal storage of lipids in the fly.
Discussion
This work shows that Lsd2 is predominantly expressed in the fat body and in the female germ line of D. melanogaster.
These two tissues are engaged in high levels of lipid metabolism. The former is the principal site of lipid storage and mobilization (Canavoso et al., 2001 ). The latter is the site of neutral lipid deposition during oogenesis, for later use during embryogenesis (Mahowald and Kambysellis, 1980) . Recently, a GFP-tagged version of Lsd2 was reported to localize to lipid storage droplets when expressed in Drosophila (Miura et al., 2002) . Here, we present electron micrographs showing that Lsd2 localizes to the surface of lipid droplets in the germ line of Drosophila females. This sub-cellular localization and its concentration in lipidenriched tissues support a function of Lsd2 in the lipid metabolism of the fly. Confirming this, we described phenotypes related to defects in this process in both the fat body and in the germ line of the Lsd2 1 mutant. We have shown that, although viable, Lsd2 mutant adults present a reduced TAG content, revealing a defect in their lipid storage capacity. This defect was suggested by the observation that, in third instar larvae, the main organ of Lsd2 expression, the fat body, is less developed than in the wild type. The Lsd2 phenotype is reminiscent of the phenotype observed in Perilipin-deficient mice (MartinezBotas et al., 2000; Tansey et al., 2001) . These mice are also viable but are leaner than the wild type, due to a defect in neutral lipid accumulation in adipocyte tissues. This similarity of phenotype supports a conservation of function in lipid storage between mammalian PAT-family members and Drosophila Lsd2. Also, in both organisms, Lsd2 and Perilipin (or ADRP) are predominantly expressed in tissues involved in fat storage.
Besides the defect in fat storage in adults, we also observed an aberrant pattern of neutral lipid accumulation in the nurse cells of Lsd2 mutant ovaries at stage 10. From this stage on, most neutral lipids do not appear as evenly dispersed discrete droplets, as they do in wild type, but form larger aggregates often radially distributed around the nurse cell nuclei. This pattern is similar to the distribution of neutral lipids and ER at earlier stages (compare insets in Fig. 4A and C) . According to the model in which lipid droplets form from the ER (reviewed in Murphy, 2001) , these large aggregates could result from the inefficient formation of lipid droplets and accumulation of neutral lipids in the ER. However, we do not observe complete colocalization of neutral lipids and an ER lumen marker either in the wild type at early stages (Fig. 4A ) or in the mutant at later stages, when the ER marker is diffusely distributed throughout the cell (data not shown). This could be due to the localization of neutral lipids and the ER marker in different sub-domains of the ER. However, we cannot exclude that the aberrant lipid structures might be not a part of the ER but localize to a different compartment. Further analysis of this phenotype may further light on the molecular function of Lsd2.
A defect in lipid droplet formation in nurse cells would be expected to interfere with lipid droplet deposition into the oocyte. Indeed, we found that the neutral lipid level is reduced in early embryos of Lsd2 mutant females. We also observed a reduced hatching rate in the progeny of these females, revealing that Lsd2 1 has a maternal effect. One hypothesis we favor is that maternal Lsd2 is required, during oogenesis, to ensure optimal deposition in the mature egg of the neutral lipid pool required later on for proper embryogenesis. In such a model, the lipid reserve would be consumed before the end of embryogenesis, in some of Lsd2 mutant progeny, and would result in a development arrest and hatching defect. Another possibility is that maternal expression of Lsd2 might be required in the embryo to guarantee the proper use of the lipid pool during its development.
In mammals, the accumulation of Perilipin or ADRP and formation of neutral lipids were shown to occur concomitantly and to be mutually stimulatory. Our analysis in the female germ line also showed that Lsd2 and neutral lipid droplet accumulation coincide after mid-oogenesis. In addition, we have shown that the lack of Lsd2 affects neutral lipid accumulation in the adult fly. It would be interesting to investigate if lipid levels also affect Lsd2 expression. This could be addressed in mutants for genes involved in lipid metabolism, such as midway, in which the enzyme converting diacylglycerol into TAG is inactivated (Buszczak et al., 2002) .
This work provides new evidence for a function of Lsd2 in D. melanogaster lipid metabolism and supports the conservation of function between PAT-family members from invertebrates to vertebrates. In the absence of Lsd2, we observed defects consistent with a role in lipid droplet biogenesis and storage. The existence of another PAT member in D. melanogaster, Lsd1, raises the possibility that the latter could sustain a sufficient level of neutral lipid metabolism in our Lsd2 mutant, possibly explaining the mildness of defects we observed. Our work also shows that D. melanogaster can be used as a new model system, particularly amenable to genetics analysis, to facilitate the understanding of the fundamental molecular mechanisms underlying the metabolism of lipid-droplets as well as the regulation of their intrinsically associated proteins.
Material and methods
Genetics
The wild-type control stock used throughout this work is w 118 : The w, EP(X)1614 insertion line was obtained from the BDGP (Rørth et al., 1998) . EP(X)1614 homozygotes are viable. To generate imprecise excisions, EP(X)1614 homozygous virgin females were crossed to the transposase source w; SbD2-3=TM6: Eighty EP(X)1614; SbD2-3 males were selected from the progeny and crossed to FM6 females in individual vials. Female progeny with an excised EP element were identified by searching for white-eyed flies with normal bristles ðSb þ Þ and one per vial was chosen. These females were crossed to FM6 males to establish stocks. We screened for imprecise excisions by PCR of stocks in which males hemizygous for the excised chromosome were viable and identified the Lsd2 1 allele.
Generation of the anti-Lsd2 serum
The entire coding region present in the EST GH06230 was amplified using the Pfu polymerase. The amplified sequence was cloned in frame with calmodulin-binding peptide (CBP) in the pCAL-n vector (Stratagene) and overexpressed in E. coli. The CBP-tagged protein was purified as recommended by Stratagene after one pass through calmodulinresin. The eluate was more than 95% enriched for the tagged-protein, as judged by Coomassie staining on a denaturing gel. Rats were immunized using four successive injections consisting of , 250 mg of the eluate mixed with the Ribi Adjuvant (Corixa). All the immunodetections shown here were obtained with crude serum.
Western-blotting procedure
Whole flies or dissected ovaries were directly homogenized in 1 £ SDS-PAGE loading buffer, boiled for 2 min and sonicated prior loading. Supernatants were separated by SDS-PAGE and transferred to PVDF membrane (Immobilon P, Millipore). After blocking in PBT (PBS, 0.1% Tween-20) with 5% non-fat dry milk, the membrane was incubated for 1 h with the anti-Lsd2 crude serum diluted to 1/4000 in PBT/1% milk. The blot was washed and incubated with HRP-conjugated anti-rat IgG (AmershamPharmacia) diluted to 1/2000 in PBT. Immunodetection was performed using enhanced chemiluminescent (ECL) reagents as recommended by the supplier (Amersham Life Science). The anti-a-tubulin monoclonal antibody DM 1A (Sigma) was diluted 1/2000.
RNA in situ hybridization and immunofluorescence detection
The procedure for in situ hybridization to whole-mount ovaries has been previously described in Vanzo and Ephrussi (2002) except that the final detection step was performed using a DAB-based colorimetric assay. RNA in situ hybridization on embryos using alkaline phosphatase was carried out as described in Beccari et al. (2002) . A digoxigenin-labeled Lsd2 RNA probe was synthesized by run-off transcription from EST GH06230. Ovaries and embryos were photographed with a Zeiss Axiophot or with a Leica laser scanning confocal microscope. Larvae were photographed with a Leica DC 500 on a dissection scope. The anti-Lsd2 crude serum was diluted to 1/2000. Nile red was supplied from Molecular Probes. For the labeling of the ER lumen, we used a transgenic line expressing an in frame fusion between GFP and Pdi, the protein disulfide isomerase (Bobinnec et al., 2003) .
Immunoelectron microscopy
Ovaries from 3 days-old females were dissected and fixed in 4% paraformaldehyde in 0.2 M phosphate buffer for 2 h at room temperature or 2% paraformaldehyde and 0.2% glutaraldehyde under the same conditions. Individual ovarioles were separated and mounted in a block of 10% gelatine. The selected stages (10) were singled out by trimming the block after freezing. Cryosections along the long axis of the egg chamber were collected using a Leica S4 ultramicrotome and processed for immunolabeling according to Liou et al. (1996) . The Lsd2 antibody (1/300) was detected using protein A coupled to 10 nm gold particles. Sections were contrasted and viewed under a Jeol electron microscope.
TAG quantification
The protocol for TAG quantification was kindly provided by Ronald Kühnlein and, while this paper was under consideration, has been published in Grönke et al. (2003) . TAG was quantified using Triglycerides (ThermoTrace). TAG content in each sample was normalized by protein concentration, quantified using the Bio-Rad Protein Assay.
Note added in proof
While this paper was under consideration, Grönke et al. (2003) published a manuscript on a similar study showing that Lsd2 controls fat storage in D. melanogaster.
